Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3660160
Max Phase: Preclinical
Molecular Formula: C10H14N4O2
Molecular Weight: 222.25
Molecule Type: Small molecule
Associated Items:
ID: ALA3660160
Max Phase: Preclinical
Molecular Formula: C10H14N4O2
Molecular Weight: 222.25
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N[C@H]1Cc2cn(C3CCC3)nc2N(O)C1=O
Standard InChI: InChI=1S/C10H14N4O2/c11-8-4-6-5-13(7-2-1-3-7)12-9(6)14(16)10(8)15/h5,7-8,16H,1-4,11H2/t8-/m0/s1
Standard InChI Key: TVBIGDQMRUAKDD-QMMMGPOBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 222.25 | Molecular Weight (Monoisotopic): 222.1117 | AlogP: 0.21 | #Rotatable Bonds: 1 |
Polar Surface Area: 84.38 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.07 | CX Basic pKa: 8.07 | CX LogP: -0.48 | CX LogD: -0.42 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.67 | Np Likeness Score: -0.22 |
1. (2013) KAT II inhibitors, |
2. (2015) KAT II inhibitors, |
Source(1):